Skip to main content

Table 2 Monthly CLA-BSI during the study period, device utilization ratio and organismscausing CLA-BSI in each month.

From: Beyond the bundle - journey of a tertiary care medical intensive care unit to zerocentral line-associated bloodstream infections

Surveillance period

Number of CLA-BSI

Central line days

CLA-BSI rate/1000 central line days

Patient days

Device utilization ratio

Organisms causing CLA-BSI

Jan-08

1

550

1.82

700

0.79

VRE faecium

Feb-08

2

547

3.66

675

0.81

Acinetobacter baumannii

Methicillin-resistant Staphylococcus epidermidis

Mar-08

3

562

5.34

739

0.76

Enterococcus faecium

Methicillin-resistant Staphylococcus epidermidis

Candida parapsilosis

Apr-08

1

470

2.13

661

0.71

Group B Streptococcus agalactiae

May-08

1

468

2.14

668

0.70

Methicillin-resistant Staphylococcus epidermidis

Jun-08

1

478

2.09

629

0.76

Enterobacter cloacae

Jul-08

0

351

0.00

626

0.56

 

Aug-08

1

340

2.94

683

0.50

Klebsiella oxytoca

Sep-08

0

360

0.00

649

0.55

 

Oct-08

0

510

0.00

691

0.74

 

Nov-08

1

518

1.93

696

0.74

Pseudomonas aeruginosa

Dec-08

2

514

3.89

699

0.74

Klebsiella pneumoniae

Methicillin-resistant Staphylococcus epidermidis

Jan-09

2

461

4.34

700

0.66

Prevotella buccae and Achromobacter xylosoxidans

Feb-09

1

474

2.11

634

0.75

Candida glabrata

Mar-09

4

568

7.04

721

0.79

Pseudomonas fluorescans, Peptostreptococcus, VREfaecium

Apr-09

0

417

0.00

639

0.65

 

May-09

1

394

2.54

644

0.61

Candida albicans, VRE faecium

Jun-09

0

358

0.00

626

0.57

 

Jul-09

3

389

7.71

673

0.58

Candida glabrata, VRE faecium, E.coli

Aug-09

2

513

3.90

684

0.75

Acinetobacter baumannii, VRE faecium

Sep-09

0

436

0.00

661

0.66

 

Oct-09

1

505

1.98

699

0.72

Pseudomonas aeruginosa

Nov-09

1

569

1.76

679

0.84

Klebsiella pneumoniae

Dec-09

2

565

3.54

728

0.78

Enterococcus faecalis, Acinetobacter baumannii

Jan-10

0

468

0.00

678

0.69

 

Feb-10

0

411

0.00

626

0.66

 

Mar-10

2

457

4.38

623

0.73

VRE faecium, VRE faecium

Apr-10

2

386

5.18

565

0.68

Methicillin-resistant Staphylococcus epidermidis, VREfaecium

May-10

0

480

0.00

615

0.78

 

Jun-10

2

479

4.18

612

0.78

Morganella morganii, Enterobacter cloacae

Jul-10

0

468

0.00

654

0.72

 

Aug-10

1

478

2.09

627

0.76

VRE faecium

Sep-10

0

423

0.00

626

0.68

 

Oct-10

2

534

3.75

711

0.75

VRE faecium, VRE faecium

Nov-10

2

532

3.76

679

0.78

VRE faecium, Methicillin- resistant Staphylococcusepidermidis

Dec-10

0

473

0.00

620

0.76

 

Jan-11

0

485

0.00

712

0.68

 

Feb-11

1

485

2.06

647

0.75

VRE faecium

Mar-11

2

535

3.74

709

0.75

VRE faecium, Enterococcus faecalis

Apr-11

0

501

0.00

641

0.78

 

May-11

0

461

0.00

677

0.68

 

Jun-11

0

448

0.00

621

0.72

 

Jul-11

0

351

0.00

655

0.54

 

Aug-11

0

454

0.00

690

0.66

 

Sep-11

0

543

0.00

705

0.77

 

Oct-11

0

473

0.00

677

0.70

 

Nov-11

0

473

0.00

653

0.72

 

Dec-11

0

473

0.00

704

0.67

 
  1. CLA-BSI, central line-associated bloodstream infections.